| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca74ed15eb9426695541087e53bd9e00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate |
2007-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42c8e6ae538ed086eb94c0fc8dc995eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64299a45ec2e197f867f4d4312519782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adbc122c5755d900f3f8fc78aaa89b88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcf124aa0467194f34941724e9247548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e89b085221df861c82581bf2c466518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff3b8c49e3da3516c19de09b7479def9 |
| publicationDate |
2013-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102617722-B |
| titleOfInvention |
Ancylostoma caninum anticoagulant peptide, preparation and application thereof |
| abstract |
The invention is division of invention patent application with application No. 200710079673.0. The present invention discloses a novel ancylostoma caninum anticoagulant peptide and an encoded sequence thereof. The anticoagulant peptide of the present invention has anticoagulant activity. With the anticoagulant peptide of the present invention, human plasma prothrombin time (PT) and activeated partial thromboplastin time (aPTT) can be significantly prolonged. In addition, the anticoagulant peptide of the present invention has a significant anti-thrombosis effect. The present invention further relates to applications of the anticoagulant peptide in preparations of anticoagulant drugs and anti-thrombotic drugs. |
| priorityDate |
2007-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |